Non-Vascular Stents Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

The stent is a small tube made of metal or plastic that is inserted into a blood vessel/duct to aid healing or relieve an obstruction. Pancreatic and Biliary Stents, Enteral Stents, Airway Stents, and Urinary Tract Stents are covered under this category. The non-vascular stents report provides key information and data related to extensive coverage of the non-vascular stents under development. The report provides details of major pipeline products which include product description, licensing and collaboration details, and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates.

What are the different categories in the non-vascular stents pipeline products market?

Airway stents, enteral stents, pancreatic and biliary stents, metal fully covered pancreatic and biliary stents, metal stents, fully covered enteral stents, and plastic biliary stents are the different categories in the non-vascular stents pipeline products market. Amongst them, airway stents, enteral stents, pancreatic and biliary stents have the highest number of products in the non-vascular stents pipeline products market.

Pancreatic and biliary stents: The pancreatic and biliary stents are thin, tube-like structures that could be inserted into the bile/pancreatic/hepatic ducts to relieve the narrowing of the ducts, this condition is known as a biliary stricture. The pancreatic and biliary stent is used to support a narrowed part of the duct and prevents the reformation of the stricture. Metal biliary stents are tubular structures made of metal and can be used to treat structures. Metal stents include uncovered and covered metal biliary stents. Plastic stents are composed of polythene, polyurethane, or Teflon and are available in different configurations. Plastic pancreatic and plastic biliary stents are covered under this category. one unit refers to one plastic stent.

Enteral stents: A stent is a perforated expandable tube that is inserted into a passage of the body in order to alleviate the constriction of flow caused by any disease. Enteral stents are primarily used to maintain the patency of the lumen of the gastrointestinal tract. Non-covered enteral stents partially covered enteral stents, and fully covered enteral stents are covered in the segment. 

Airway stents: An airway stent is a hollow tube-shaped device that is inserted into an airway to relieve the obstruction. It is also known as a tracheobronchial stent. Metallic airway stents and silicone airway stents are the devices tracked under this segment.

Metallic airway stents: Metallic airway stents are mainly referred to as self-expandable metallic stents (SEMS) which are composed of metallic mesh wires and most of the SEMS are not used in non-malignant disorders. Whereas the expandable metal stents have the advantage of the ease of insertion, confirmation to the airway, low inner to outer diameter ratio, and stent stability.

Silicone airway stents: A silicone airway stent is made from medical-grade silicone with studs on the external surface. It requires rigid bronchoscopy for deployment. One unit refers to one silicone airway stent.

Non-vascular stents pipeline products market, by categories

Non-vascular stents pipeline products market, by categories

For more segment insights, download a free report sample

Which are the key territories in the non-vascular stents pipeline products market?

The US, India, Japan, China, Colombia, Costa Rica, Ecuador, Egypt, El Salvador, Europe, Israel, Argentina, Brazil, Chile, Mexico, and Singapore. Amongst them, the US has the highest number of products in the pipeline stage, followed by India and Japan.

Non-vascular stents pipeline products market, by territories

Non-vascular stents pipeline products market, by territories

For more regional insights, download a free report sample

Which are the key companies in the non-vascular stents pipeline products market?

All India Institute of Medical Sciences, amg International GmbH, Boston Scientific Corp, Broncus Medical Inc, Embryyo Technologies Pvt Ltd, Massachusetts Institute of Technology, Merit Medical Systems Inc, Peytant Solutions Inc, QualiMed Innovative Medizinprodukte GmbH, Safeheal are some of the key companies in the non-vascular stents pipeline products market.

Company overview

All India Institute of Medical Sciences: All India Institute of Medical Sciences (AIIMS) is a medical institution that provides medical education, biomedical research, and healthcare services. It offers undergraduate, postgraduate, and doctorate programs in nursing, audiometry, ophthalmic, techniques, and radiography. The institution also provides DM (Doctor of Medicine) and MCh (Master of Chirurgiae) super-specialty courses in the areas of cardiology, gastroenterology, endocrinology, neurology, nephrology, oncology, cardiothoracic and neurosurgery.

amg International GmbH: amg International GmbH (amg International) is a medical device company that develops, manufactures and markets stents, stent implantation systems and balloon catheters, and other auxiliary products. The company provides coronary vascular intervention products and peripheral vascular intervention products. amg International coronary vascular interventional products include drug-eluting stents, bare-metal stents, ITRAC guide wire, PTCA balloons, ITRAC plus guidewire, and other accessories. amg International’s peripheral vascular interventional products include thalis inert balloon-expandable stent, FACILE self-expendable peripheral stent-implantation system, and Allunga PTA balloon.

Boston Scientific Corp: Boston Scientific Corp (Boston Scientific) is a medical technology company that develops, manufactures, and commercializes devices for a range of interventional medical specialties. The company offers products in the areas of electrophysiology, gastroenterology, gastrointestinal surgery, female pelvic medicine, gynecology, interventional cardiology, interventional radiology, neurological surgery, orthopedic surgery, pain medicine, pulmonology, urology and vascular surgery. Boston Scientific serves hospitals, clinics, outpatient facilities, and medical offices across the world.

Broncus Medical Inc: Broncus Medical Inc (Broncus), formerly Broncus Technologies Inc, is a medical device company that develops navigation, diagnostic and therapeutic technologies for the treatment of patients with lung disease. The company offers the Archimedes system, a total lung access platform used for virtual bronchoscopic planning, navigation, and tunneling. It also provides Archimedes Planner, a portable pre-procedure planning and simulation system for ArchimedesFlexNeedle, a transbronchial aspiration needle. The company offers Lungpoint Virtual Bronchoscopic Navigation (VBN) system that provides real-time path navigation within the lungs for lung biopsy and other DX/TX proceduresand Lungpoint Planner, a portable pre-procedure planning and simulation system for VBN. Broncus is headquartered in San Jose, California, the US.

Merit Medical Systems Inc: Merit Medical Systems Inc (Merit Medical) offers a range of single-use medical devices for interventional and diagnostic procedures. The company’s products include inflation devices and accessories, diagnostic and therapeutic catheters, diagnostic and hydrophilic products, thrombolytic catheters and fluid dispensing systems, and embolotherapy products. Merit Medical’s products find applications in various diagnostic and interventional cardiology fields including radiology, cardiology and endoscopy, and other clinical areas such as thoracic surgery, interventional nephrology, vascular surgery, oncology, and pain management. It markets its products through a direct sales force in the US and Western Europe, and Chinaand through independent dealer organizations and a network of OEM partners in the Americas, Europe, Africa, the Middle East, Asia, and Oceania. Merit Medical is headquartered in South Jordan, Utah, the US.

Non-vascular stents pipeline products market, by key companies

Non-vascular stents pipeline products market, by key companies

To know more about key players, download a free sample

Market report scope

Key categories Airway stents, enteral stents, pancreatic and biliary stents, metal fully covered pancreatic and biliary stents, metal stents, fully covered enteral stents, and plastic biliary stents
Key territories  The US, India, Japan, China, Colombia, Costa Rica, Ecuador, Egypt, El Salvador, Europe, Israel, Argentina, Brazil, Chile, Mexico, and Singapore
Key Companies All India Institute of Medical Sciences, amg International GmbH, Boston Scientific Corp, Broncus Medical Inc, Embryyo Technologies Pvt Ltd, Massachusetts Institute of Technology, Merit Medical Systems Inc, Peytant Solutions Inc, QualiMed Innovative Medizinprodukte GmbH, and Safeheal

Scope:

  • Extensive coverage of the non-vascular stents under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details, and other developmental activities
  • The report reviews the major players involved in the development of non-vascular stents and lists all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of non-vascular stents under development.
  • Develop market entry and market expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date

All India Institute of Medical Sciences
amg International GmbH
Boston Scientific Corp
Broncus Medical Inc
Embryyo Technologies Pvt Ltd
Massachusetts Institute of Technology
Merit Medical Systems Inc
Peytant Solutions Inc
QualiMed Innovative Medizinprodukte GmbH
Safeheal
Taewoong Medical Co Ltd
University of Pittsburgh

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 4

|1.2 List of Figures 6

2 Introduction 7

2.1 Non-Vascular Stents Overview 7

3 Products under Development 8

3.1 Non-Vascular Stents – Pipeline Products by Stage of Development 8

3.2 Non-Vascular Stents – Pipeline Products by Segment 9

3.3 Non-Vascular Stents – Pipeline Products by Territory 10

3.4 Non-Vascular Stents – Pipeline Products by Regulatory Path 11

3.5 Non-Vascular Stents – Pipeline Products by Estimated Approval Date 12

3.6 Non-Vascular Stents – Ongoing Clinical Trials 13

4 Non-Vascular Stents – Pipeline Products under Development by Companies 14

4.1 Non-Vascular Stents Companies – Pipeline Products by Stage of Development 14

4.2 Non-Vascular Stents – Pipeline Products by Stage of Development 15

5 Non-Vascular Stents Companies and Product Overview 16

5.1 All India Institute of Medical Sciences Company Overview 16

5.1.1 All India Institute of Medical Sciences Pipeline Products & Ongoing Clinical Trials Overview 16

5.2 amg International GmbH Company Overview 17

5.2.1 amg International GmbH Pipeline Products & Ongoing Clinical Trials Overview 17

5.3 Boston Scientific Corp Company Overview 22

5.3.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 22

5.4 Broncus Medical Inc Company Overview 26

5.4.1 Broncus Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 26

5.5 Embryyo Technologies Pvt Ltd Company Overview 27

5.5.1 Embryyo Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 27

5.6 Massachusetts Institute of Technology Company Overview 28

5.6.1 Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 28

5.7 Merit Medical Systems Inc Company Overview 29

5.7.1 Merit Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 29

5.8 Peytant Solutions Inc Company Overview 30

5.8.1 Peytant Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 30

5.9 QualiMed Innovative Medizinprodukte GmbH Company Overview 31

5.9.1 QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview 31

5.10 Safeheal Company Overview 32

5.10.1 Safeheal Pipeline Products & Ongoing Clinical Trials Overview 32

5.11 Taewoong Medical Co Ltd Company Overview 33

5.11.1 Taewoong Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 33

5.12 University of Pittsburgh Company Overview 38

5.12.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 38

6 Non-Vascular Stents- Recent Developments 39

6.1 Feb 17, 2021: Medtronic Executives to Speak at Upcoming Investor Conferences 39

6.2 Feb 16, 2021: Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2021 39

7 Appendix 40

7.1 Methodology 40

7.2 About GlobalData 43

7.3 Contact Us 43

Table

Non-Vascular Stents – Pipeline Products by Stage of Development 8

Non-Vascular Stents – Pipeline Products by Segment 9

Non-Vascular Stents – Pipeline Products by Territory 10

Non-Vascular Stents – Pipeline Products by Regulatory Path 11

Non-Vascular Stents – Pipeline Products by Estimated Approval Date 12

Non-Vascular Stents – Ongoing Clinical Trials 13

Non-Vascular Stents Companies – Pipeline Products by Stage of Development 14

Non-Vascular Stents – Pipeline Products by Stage of Development 15

All India Institute of Medical Sciences Pipeline Products & Ongoing Clinical Trials Overview 16

Biodegradable Airway Stent – Product Status 16

Biodegradable Airway Stent – Product Description 16

amg International GmbH Pipeline Products & Ongoing Clinical Trials Overview 17

ARCHIMEDES Biodegradable Biliary And Pancreatic Stent – Product Status 17

ARCHIMEDES Biodegradable Biliary And Pancreatic Stent – Product Description 18

UNITY-B Biliary Stent – Product Status 18

UNITY-B Biliary Stent – Product Description 18

amg International GmbH – Ongoing Clinical Trials Overview 19

ARCHIMEDES Biodegradable Biliary And Pancreatic Stent – A Prospective, Multi-center, Single-arm, Post Market Observational Study to Evaluate the Safety and Clinical Performance of the Archimedes Biodegradable Biliary and Pancreatic Stent 20

ARCHIMEDES Biodegradable Biliary And Pancreatic Stent – Prospective Evaluation of the Use of a Biodegradable Endoprothesis in the Prevention of Post-Endoscopic Retrograde CholoangioPancreatography Pancreatitis 20

ARCHIMEDES Biodegradable Biliary And Pancreatic Stent – Prospective Observational Cohort Study: To Assess the Utility of Bio-degradable Bile Duct Stent in the Drainage of Bile Duct 20

UNITY-B Biliary Stent – UNITY-B A Prospective, Multicentric, Single-arm Study to Evaluate the Safety and Efficacy of the UNITY-B Biodegradable Balloon-Expandable Biliary Stent System in Subjects with Biliary Strictures 21

Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 22

Axios Transluminal Stent – Product Status 22

Axios Transluminal Stent – Product Description 23

Boston Scientific Corp – Ongoing Clinical Trials Overview 24

Axios Transluminal Stent – Gastroenteric Anastomosis with Natural Orifice Translumenal Endoscopic Surgery (NOTES) Using the New Fashioned Tissue Apposing Stent Axios for the Treatment of Antro-pyloric or Duodenal Obstructions : Prospective Evaluation of Feasibility, Efficacy and Tolerance 25

Broncus Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 26

Exhale Drug Eluting Stent – Product Status 26

Exhale Drug Eluting Stent – Product Description 26

Embryyo Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 27

Self Expandable Esophageal Stent – Product Status 27

Self Expandable Esophageal Stent – Product Description 27

Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 28

Kirigami Stent – Product Status 28

Kirigami Stent – Product Description 28

Merit Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 29

EndoMAXX EDT Esophageal Stent – Product Status 29

EndoMAXX EDT Esophageal Stent – Product Description 29

Peytant Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 30

AMStent – Product Status 30

AMStent – Product Description 30

QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview 31

Biliary 0.035” OTW Stent – Product Status 31

Biliary 0.035” OTW Stent – Product Description 31

Safeheal Pipeline Products & Ongoing Clinical Trials Overview 32

Colovac – Product Status 32

Colovac – Product Description 32

Taewoong Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 33

Niti-S Comvi Biliary Stent – Product Status 33

Niti-S Comvi Biliary Stent – Product Description 33

Niti-S Kaffes Biliary Stent – Product Status 34

Niti-S Kaffes Biliary Stent – Product Description 34

Niti-S S Biliary Covered Stent – Product Status 34

Niti-S S Biliary Covered Stent – Product Description 35

Taewoong Medical Co Ltd – Ongoing Clinical Trials Overview 36

Niti-S Kaffes Biliary Stent – The Safety and Efficacy of a Short Specially Designed Fully Covered Metallic Stent in the Management of Benign Post-surgical Biliary Strictures: A Randomized-controlled Study 37

University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 38

Esophocclude – Product Status 38

Esophocclude – Product Description 38

Figures

Non-Vascular Stents – Pipeline Products by Stage of Development 8

Non-Vascular Stents – Pipeline Products by Segment 9

Non-Vascular Stents – Pipeline Products by Territory 10

Non-Vascular Stents – Pipeline Products by Regulatory Path 11

Non-Vascular Stents – Pipeline Products by Estimated Approval Date 12

Frequently asked questions

Non-Vascular Stents Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 standard reports
Currency USD
$2,500

Can be used by individual purchaser only

$7,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Non-Vascular Stents Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Non-Vascular Stents Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 in real time.

  • Access a live Non-Vascular Stents Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.